NCT04300140 2023-10-30Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaAravive, Inc.Phase 1/2 Terminated72 enrolled
NCT03636256 2023-08-14Evaluation of NanoDoceĀ® in Participants With Urothelial CarcinomaNanOlogy, LLCPhase 1/2 Completed36 enrolled 18 charts
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled